Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03751007
Brief Title: A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

First Submitted : November 8, 2018
First Submitted that Met QC Criteria : November 20, 2018
First Posted : November 23, 2018

Last Update Submitted that Met QC Criteria : February 9, 2021
Last Update Posted : February 11, 2021